Association of allergic diseases and epilepsy with risk of glioma, meningioma and acoustic neuroma: results from the INTERPHONE international case-control study.
Allergies
Brain tumours
Epilepsy
Multicenter case–control study
Journal
European journal of epidemiology
ISSN: 1573-7284
Titre abrégé: Eur J Epidemiol
Pays: Netherlands
ID NLM: 8508062
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
04
10
2021
accepted:
16
01
2022
pubmed:
5
2
2022
medline:
23
6
2022
entrez:
4
2
2022
Statut:
ppublish
Résumé
We investigated the association of allergic diseases and epilepsy with risk of brain tumours, in Interphone, a 13-country case-control study. Data were obtained from 2693 glioma cases, 2396 meningioma cases, and 1102 acoustic neuroma cases and their 6321 controls. Conditional logistic regression models were used to estimate pooled odds ratios (ORs) and their respective 95% confidence intervals (CIs), adjusted for education and time at interview. Reduced ORs were observed for glioma in relation to physician-diagnosed asthma (OR = 0.73; CI 0.58-0.92), hay fever (OR 0.72; CI 0.61-0.86), and eczema (OR 0.78, CI 0.64-0.94), but not for meningioma or acoustic neuroma. Previous diagnosis of epilepsy was associated with an increased OR for glioma (2.94; CI 1.87-4.63) and for meningioma (2.12; CI 1.27-3.56), but not for acoustic neuroma. This large-scale case-control study adds to the growing evidence that people with allergies have a lower risk of developing glioma, but not meningioma or acoustic neuroma. It also supports clinical observations of epilepsy prior to the diagnosis of glioma and meningioma.
Identifiants
pubmed: 35118581
doi: 10.1007/s10654-022-00843-y
pii: 10.1007/s10654-022-00843-y
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
503-512Informations de copyright
© 2022. Springer Nature B.V.
Références
Schlehofer B, Siegmund B, Linseisen J, et al. Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohort. Allergy. 2011;66:1434–41. https://doi.org/10.1111/j.1398-9995.2011.02670.x .
doi: 10.1111/j.1398-9995.2011.02670.x
pubmed: 21726235
Ostrom QT, Bauchet L, Davis FG, et al. The epidemiology of glioma in adults : a « state of the science » review. Neuro Oncol. 2014;16:896–913. https://doi.org/10.1093/neuonc/nou087 .
doi: 10.1093/neuonc/nou087
pubmed: 24842956
pmcid: 4057143
Turner MC, Krewski D, Armstrong BK, et al. Allergy and brain tumors in the INTERPHONE study: pooled results from Australia, Canada, France, Israel, and New Zealand. Cancer Causes Control. 2013;24:949–60. https://doi.org/10.1007/s10552-013-0171-7 .
doi: 10.1007/s10552-013-0171-7
pubmed: 23443320
Vecht CJ, Kerkhof M, Duran-Pena A. Seizure prognosis in brain tumors : new insights and evidence-based management. Oncologist. 2014;19:751–9. https://doi.org/10.1634/theoncologist.2014-0060 .
doi: 10.1634/theoncologist.2014-0060
pubmed: 24899645
pmcid: 4077452
Prakash O, Lukiw WJ, Peruzzi F, et al. Gliomas and seizures. Med Hypotheses. 2012;79:622–6.
doi: 10.1016/j.mehy.2012.07.037
The Interphone Study Group. Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case–control study Int J Epidemiol. 2010;39: 675–94
The INTERPHONE Study Group. Acoustic neuroma risk in relation to mobile telephone use: Results of the INTERPHONE international case-control study Cancer Epidemiol 2011. 35: 453–64
Zhao H, Cai W, Su S, et al. Allergic conditions reduce the risk of glioma: a meta-analysis based on 128,936 subjects. Tumor Biol. 2014;35:3875–80.
doi: 10.1007/s13277-013-1514-4
Ostrom QT, Fahmideh MA, Cote DJ, et al. Risk factors for childhood and adult primary brain tumors. Neuro Oncol. 2019;21:1357–75. https://doi.org/10.1093/neuonc/noz123 .
doi: 10.1093/neuonc/noz123
pubmed: 31301133
pmcid: 6827837
Buckingham SC, Robel S. Glutamate and tumor-associated epilepsy: Glial cell dysfunction in the peritumoral environment. Neurochem Int. 2013;63:696–701. https://doi.org/10.1016/neuint.2013.01.027 .
doi: 10.1016/neuint.2013.01.027
pubmed: 23385090